Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Biotech / Life Sciences

First Person: How to Identify and Build a Robust Community Ecosystem to Attract New Businesses

Michael Flynn, Senior Director, Economic Development, Destination Medical Center (DMC) (Q4 2023)

Creating an exceptional business environment to attract certain industries can be a daunting task for any community’s leaders. However, it can be done with focused introspection, research, and strong partnerships. Area Development’s staff editor Lisa Bastian asked Michael Flynn, senior director of Economic Development at Destination Medical Center (Rochester, MN), for his ideas on ecosystem formation. More

Innovation Flourishes In Virginia's Richmond Petersburg Corridor

Virginia Economic Development Partnership (Q2 2023)

The Richmond-Petersburg region has brought together industry, educational institutions, and government organizations to secure the pharmaceutical supply chain and advance manufacturing in the sector. More

Development Land Demonstrates Resilience in a Volatile Market

Matt Davis, Senior Director, Capital Markets; John McWilliams, Senior Research Analyst; and Andy Slowik, Managing Director, Land Brokerage; Cushman & Wakefield (Q2 2023)

Land development is a fluid sector that tends to follow the wave of national trends and demand, creating pockets of positives throughout a troubled marketplace. More

New York City Emerges as a Global Life Sciences Hub

NYCEDC (Q2 2023)

In NYC, the stage is set like no other city for life sciences companies of all sizes to thrive. More

Life Sciences are Flourishing in Kansas

Kansas Department of Commerce  (Q2 2023)

When it comes to the life sciences, Kansas means business. Investment in the fast-growing field is making the state a top place for research, discovery, and production of new technologies to improve the health of people, animals, and other living things. More

Life Science Conversions in Real Estate

Matthew Weinstein, Chair, Real Estate Lease Structuring, Cozen O’Connor (Q2 2023)

Among the key legal issues to be considered when converting office to life science space are credit enhancements, expansion/contraction options, use segregation, and zoning. More

Four Keys to Effective Life Sciences Work Transformation

Kevin Wayer, President, Government, Education, Infrastructure and Life Sciences , JLL (Q2 2023)

The future of work lies in the hands of leaders who understand what today’s life sciences workers value — and act like it. More

Challenges & Opportunities in the Canadian Life Sciences and Health Technology (LSHT) Industry

Marc Beauchamp, Managing Director, Hickey Canada (Location Canada 2022)

The government’s strategy to ensure the growth of its life sciences sector, along with the country’s high-quality talent and low operational costs among other advantages, makes Canada the place to invest in the LSHT sector. More

Future Forward

The Miami-Dade Beacon Council (Q3 2022)

Diverse and determined, Miami’s tech ecosystem has transformed it from the Magic City to Innovation City. More

To Cluster or Not to Cluster…That is the Question!

Rich Thompson, International Director, Supply Chain & Logistics Solutions, JLL (Q3 2022)

Although clusters are here to stay in some sectors — think life sciences — other industries — among them EVs and semiconductors — are geographically branching out. More

New Research Center Battles Obesity Epidemic with an Entrepreneurial Approach

Ted Griggs (Q3 2022)

From advanced radiopharmaceutical development to breakthrough diabetes treatments, innovative genome sequencing to cutting-edge water management research, Louisiana’s rapidly expanding life sciences sector is establishing the state as a hub of research, collaboration, and innovation — and creating new opportunities for biotech investment. Among these investments is the new Pennington Biomedical Research Center, which is battling the obesity epidemic with an entrepreneurial approach. More

Explosive Growth of Life Sciences Sector Comes with Challenges

Deb Boucher, Vice Chair, Cushman & Wakefield and Jason D'Orlando, Senior Managing Director, Cushman & Wakefield (Q3 2022)

Although opportunities abound, companies in the life sciences sector are also facing numerous challenges — from accessing skilled labor to deciding whether to build out or retrofit existing space. More

2022 Gold & Silver Shovel Awards Project of the Year: Regeneron Expanding Research, Manufacturing in New York

Steve Kaelble, Staff Editor, Area Development (Q2 2022)

The company’s response to COVID-19 is widely known, and it is building out its R&D and manufacturing in Tarrytown, N.Y. More

Retrofitting Office Space to Attract Life Sciences Companies

John O'Reilly, Managing Director, Unispace Life Sciences and Aisling Crowley, Head of Client Relations & Strategy, Unispace Life Sciences (Q2 2022)

In the life sciences industry, business is booming; here’s how office buildings can satisfy the sector’s unflagging demand for space. More

Innovative and Collaborative Design Sets the Stage for Life Science Innovation

Dr. Suzet McKinney, Principal and Director of Life Sciences, Sterling Bay (Q2 2022)

Life science labs need to accommodate present and future equipment needs and, most importantly, collaboration among the scientists and others who work there. More

Warm Economic Welcomes in the Caribbean

Steve Kaelble, Staff Editor, Area Development (Q1 2022)

From strong connections in its U.S. territories to a wealth of industrial opportunities throughout the region, the Caribbean offers more than just fun in the sun. More

Editor's Note: Consumer Spending & Business Innovation Foster Growth

Geraldine Gambale, Editor, Area Development Magazine (Q4 2021)

The food/agri-business and the biopharma sectors were among those experiencing growth in 2021, spurred by innovations brought about during the pandemic. More

Shaping Compliance for Your New Biomanufacturing Facility

Roger Humphrey, Division President, Life Sciences, JLL (Q4 2021)

If you have a new biomanufacturing site in the works, you can open doors to a productive, compliance-forward facility with these strategies. More

Location Factors for Cell and Gene Therapy Companies

Catherine Scangarella , Chief Business Development Officer, Choose New Jersey (Q4 2021)

The rise of cell and gene therapy (CGT) demands a strong supply chain, manufacturing operations, and specialized talent. More

On the Hunt for a Productive New Biomanufacturing Site?

Travis McCready, Executive Director, U.S. Life Sciences Markets, JLL (Q4 2021)

Real estate and facility strategy can fuel efficiency, scale, and speed to market for your new biomanufacturing operation More

Where's the Talent: Jobs Outlook in the Fastest Growing U.S. Cities

Michael Reid, Senior Economist, Oxford Economics and Barbara Denham, Senior Economist, Oxford Economics (Q2 2021)

Unlike in past expansions, growth may spread across more cities as more people have the freedom to work remotely from their preferred locations. More

Life Sciences Fueling Construction Demand

Gul Dusi, Linesight (Q2 2021)

In the wake of the pandemic, life sciences companies are rapidly expanding, spurring a demand for new facilities to house their operations. More

Editor's Note: Is There a “Better Normal” Ahead?

Geraldine Gambale, Editor, Area Development Magazine (Q4 2020)

The global pandemic has brought into focus the rise of e-commerce, including in the food and beverage industry, and the importance of the life sciences sector, while also redefining workforce. More

Robust Development Plan Encourages Innovation and Expertise

Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency (Q4 2020)

Venture capital groups are raising money to invest in U.S.- based infrastructure for large-scale bio-therapy manufacturing, the need for which was highlighted by the COVID-19 pandemic. More

How to Navigate the Reshoring of Pharmaceutical Manufacturing

Darren Jones, John Finan, and Cory Wendt, Baker Tilly US, LLP (Q4 2020)

With global vulnerabilities in the supply chain and the ever-changing landscape of the “new normal,” pharma industry leaders need to have a clear map for the road ahead. More

Redevelopment of Space for Booming Life Sciences Firms

Jeff Janicek, Jeff Janicek, Skender (Q4 2020)

As life sciences firms look to ramp up production, many are considering redevelopment of sites formerly put to other uses. More

Innovating During COVID-19: New Jersey’s Next Era in Life Sciences

Choose New Jersey (Q3 2020)

Following 150 years of global leadership in life sciences, cell and gene therapy (CGT) is rapidly accelerating within the New Jersey ecosystem. More

Innovation in America Reaches New Heights

Lisa A. Bastian (Q2 2020)

If necessity is the mother of invention, the COVID-19 crisis is driving cooperative innovation by companies, government entities, and healthcare organizations. More

An Innovative P3 for a Multibillion-Dollar Medical Center

Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency (Q2 2020)

Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency, spoke with Area Development about the largest public-private economic initiative in Minnesota’s history, at our Women in Economic Development Consultants Forum. More

In Focus: 3D Printing Continues to Rock Manufacturing

John Hornick, Chief Strategy & Communications Officer, nScrypt (Q1 2020)

Manufacturing — not just printing — fully functioning parts and biomanufacturing are on the horizon for 3D. More

Greater Memphis Plans to Build Upon Its Success

Mark Crawford, Staff Editor, Area Development (Q1 2020)

Known for its logistics, Memphis is also a growing center for healthcare and technology. More

Life Sciences’ Quest for a Future-Friendly Real Estate Strategy

Roger Humphrey, Division President, Life Sciences, JLL (Q4 2019)

Record-breaking R&D investment in the life sciences industry is spurring real estate innovation too. More

2019 Gold & Silver Shovel Awards Project of the Year: Life Sciences Company Regeneron Expanding in New York State

Steve Kaelble, Staff Editor, Area Development (Q2 2019)

Regeneron’s $800 million, 1,500-employee expansion will fuel growth in the Capital Regions as well as lifesaving innovation. More

Location Notebook: Indiana Is Making Global Connections

Steve Kaelble, Staff Editor, Area Development (Q2 2019)

Both domestic and foreign advanced technology and other firms are investing in Indiana, a state with a well-prepared workforce and lifestyle initiatives to attract younger workers. More

How Location Strategy Can Fuel Drug Discovery

Roger Humphrey, Division President, Life Sciences, JLL (Q4 2018)

Life sciences companies are seeking locations where they can attract top talent and identify flexible facilities, which is directly affecting their real estate decisions. More

How Innovation and Tourism Work Side By Side in Orlando

Mark Crawford, Staff Editor, Area Development (Q2 2018)

The success of Orlando’s theme park industry and cross-disciplinary technology innovation have led to the region becoming a leading destination for high-tech companies. More

Location Notebook: Cape Coral-Desirable for Business Owners and Residents Alike

Steve Kaelble, Staff Editor, Area Development (Q1 2018)

A pro-business environment and an enviable quality of life have made Cape Coral a haven for biomedical and other light manufacturing companies. More

The U.S. Is Serious About Life Sciences

Karen Thuermer, Staff Editor, Area Development (Q4 2017)

The biopharmaceutical and life science industries are recognized as important economic drivers across the nation. More

Lab Space is Hard to Find in Top U.S. Life Sciences Clusters

Roger Humphrey, Division President, Life Sciences, JLL (Q2 2017)

The 5th annual JLL report identifies where life sciences companies are locating — and the trends driving them there. More

Frontline: 21st Century Cures Act May Spur Pharma/ Medical Device Expansions in U.S.

Dan Emerson, Staff Editor, Area Development (Q1 2017)

Funding provided by the 21st Century Cures Act, as well changes in FDA approval procedures, may lead pharma and medical device companies to expand their operations, with an eye on U.S. locations to accommodate the new administration’s interventions. More

Exclusive Research